Article
How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia
3 Oct 2019
Abstract excerpt
Advances in our understanding of mechanisms of leukemogenesis and driver mutations in acute lymphoblastic leukemia (ALL) lead to a more precise and informative sub-classification, mainly of B-cell ALL. In parallel, in recent years, novel agents have been approved for the therapy of B-cell ALL, and many others are in active clinical research. Among the newly recognized disease subtypes,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
